Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Latest filing published 16 May 2026 for M&G plc, €11k. Read the official filing
Filing timeline
BuySaleChristopher Cochrane
Insider track record
Disclosed buys
0
Disclosed sells
5
Signal history
Closed purchases
Market purchases
2
Positive at T+90
100%
Median T+90
+19.9%
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -0.7%Entry £3.06 · Close 09 Oct 2026 £3.04
- +42.9%Entry £2.20 · Close at T+365 £3.15
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Christopher Cochrane: trading record in brief
Christopher Cochrane appears in our data through filings on M&G plc shares, published by RNS (LSE). Between 1 April 2025 and 13 May 2026, the trades on record add up to 8 filings.
Every open-market trade on record is a sale: 5 sales worth €27k. Outside the open market, there are 3 share grants. In 2026 alone, the filings show no purchases and 3 sales.
The newest entry dates from 16 May 2026: an open-market sale of €11k, in M&G plc. Filings reach the RNS (LSE) feed a median of 2 days after the trade. Under the UK Market Abuse Regulation, managers have three business days to notify their trades. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.
Companies and markets linked to Christopher Cochrane
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
10,287 shares@ £3.04220.0001% mcap100.0% of flowXLONISIN GB00BKFB1C65RNS:9569256-1
3,297 shares@ £3.01880.0001% mcap72.4% of flowXLONISIN GB00BKFB1C65RNS:b090a211-aba1-4938-8297-b6b1b997279d-1
18 shares@ £3.00890.0000% mcap0.4% of flowXLONISIN GB00BKFB1C65RNS:6eebd5b6-479a-410b-8303-9cdb663f60c4-0
Canonical exit: 29 Jul 2026 (T+90)
00.0000% mcap0.0% of flowXLONISIN GB00BKFB1C65RNS:dff238ea-ae14-4077-aa47-78b169949ee7-1
1,261 shares@ £2.816925.6% of flowISIN GB00BKFB1C65RNS:48712d2b-beb6-4fa8-bbc5-4db433148517
94 shares@ £2.17761.5% of flowXLONISIN GB00BKFB1C65RNS:5652604-0
Canonical exit: 7 Aug 2025 (T+90)
00.0% of flowXLONISIN GB00BKFB1C65RNS:5603282-1
00.0% of flowOutside a trading venueISIN GB00BKFB1C65RNS:5599436-1
8 of 8 declarations
